Erdosteine reduces inflammation and time to first exacerbation postdischarge in hospitalized patients with AECOPD

Maurizio Moretti,1 Stefano Fagnani2 1Respiratory Unit, Massa-Carrara Hospital and University of Pisa, Pisa, Italy; 2Medical Department, Edmond Pharma Srl, Paderno Dugnano, Milan, Italy Purpose: Mucolytics can improve disease outcome in patients with acute exacerbations of chronic obstructive pulmo...

Full description

Bibliographic Details
Main Authors: Moretti M, Fagnani S
Format: Article
Language:English
Published: Dove Medical Press 2015-10-01
Series:International Journal of COPD
Online Access:https://www.dovepress.com/erdosteine-reduces-inflammation-and-time-to-first-exacerbation-postdis-peer-reviewed-article-COPD